Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Cash from Investing Activities: 2023-2025

Historic Cash from Investing Activities for CG Oncology (CGON) over the last 3 years, with Sep 2025 value amounting to $15.0 million.

  • CG Oncology's Cash from Investing Activities fell 52.99% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$159.4 million, marking a year-over-year increase of 46.17%. This contributed to the annual value of -$300.8 million for FY2024, which is 148.17% down from last year.
  • Per CG Oncology's latest filing, its Cash from Investing Activities stood at $15.0 million for Q3 2025, which was up 969.30% from $1.4 million recorded in Q2 2025.
  • Over the past 5 years, CG Oncology's Cash from Investing Activities peaked at $103.4 million during Q2 2023, and registered a low of -$307.4 million during Q1 2024.
  • Moreover, its 3-year median value for Cash from Investing Activities was $1.4 million (2025), whereas its average is -$53.8 million.
  • Data for CG Oncology's Cash from Investing Activities shows a peak YoY increase of 119.83% (in 2024) and a maximum YoY decrease of 290.66% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows CG Oncology's Cash from Investing Activities stood at $15.5 million in 2023, then fell by 29.80% to $10.9 million in 2024, then slumped by 52.99% to $15.0 million in 2025.
  • Its Cash from Investing Activities stands at $15.0 million for Q3 2025, versus $1.4 million for Q2 2025 and -$186.8 million for Q1 2025.